MBOT Stock
MBOT Stock

The stock of Exantas Capital Corp. (NYSE:XAN) is now priced at $2.37 and the shares are 0.14 points up or 6.28% higher compared to its previous closing price of $2.23. The stock had 1.472 million contracts set over the past session. XAN shares’ daily volume is compared to its average trading volume at 1.557 million shares. However, it has a float of 31.04 million and although its performance was 5.33% over the week, it’s one to watch. It means the stock’s downside potential is -100% with the XAN share price recently placing at $2.27 to $2.52. However, some brokerage firms have priced the stock below the average, including one that has called $4.

The shorts are running away from the Exantas Capital Corp. stock, with the latest data on short interest released on June 30, 2020, showing that short interest numbers in the XAN shares have declined. Short interest in the stock represents just 5.29% of its float, but the volume has dropped by 0.

In the last trading session, Exantas Capital Corp. (NYSE:XAN) raised by $0.12 over the week and gained $0.06 on its 20-day. The stock’s high in the recent session is lower when compared to its 52-week high of $12.51. The stock recorded its established 52-week high on 02/25/20.

Since 04/03/20, the stock has traded to a low of $0.95 at 149.47%, an encouraging piece of data likely to interest most investors out to exploit the stock’s recent surge. The stock has a beta allocation of 1.37. Being above 1 means that the stock’s volatility is higher than the market and traders are keenly watching it.

Looking at current readings, Exantas Capital Corp.’s two-week RSI is 49.29. This suggests that the stock is neutral at the moment and that XAN shares’ price movement remains stable. The stochastic readings are equally revealing at 26.67% meaning the XAN share price is currently in overbought territory.

The technical chart shows that the XAN stock will likely settle at between $2.5 and $2.64 per share. However, if the stock dips below $2.25, then its market would become much weaker. Any downside could see the stock price sliding to levels as low as $2.14.

Currently, the stock is trading in the red of MACD, with a reading of -0.03. Investors always pay attention to any move above or below the zero-line, mainly because the indicator points to the position of the stock’s short-term average relative to its long-term measure. A MACD -a reading above the zero line means that the short-term is above the long-term average. This scenario implies that there is an upward momentum. The opposite is true when the MACD falls below the zero-line.

Analysts at Raymond James cut their recommendation for XAN from Outperform to Mkt Perform in April 13 review. BTIG Research analysts see the stock as a Buy with a target price of $ in a flash note released to investors on October 09 initiating covering the stock.

The average rating for the XAN equity is 2.5 and is currently gathering a bullish momentum. Of 2 analysts tracking Exantas Capital Corp. polled by Reuters, 1 rated XAN as a hold. The remaining 1 analysts were split evenly. However, the split wasn’t equal as a majority (1) rated it as a buy or strong buy. 0 analyst advised investors against buying the stock or to sell if they own any of the stock.

Elsewhere, the XAN stock price is 4.84X ahead of its 12-month Consensus earnings per share estimates.

Zacks Consensus Estimate forecasts that the current-quarter revenues for Exantas Capital Corp. (NYSE:XAN) will decrease by about -100.01%, which will see them reach $13.45 million. The company’s full-year revenues are, however, expected to diminish by about -3.92%, down from $61.15 million to $58.75 million. XAN’s expected adjusted earnings should drop almost -35.71% to end up at $0.18 per share, while for the fiscal year, analysts project the company’s earnings to drop by about -17.76% to record $0.88/share.


Please enter your comment!
Please enter your name here